Oral Urea Administration for Hyponatremia
For patients with hyponatremia due to SIADH, administer oral urea at a dose of 30-40 grams per day, divided into three or four doses (typically 15 grams three times daily or 10 grams four times daily), mixed in 100-150 mL of normal saline or juice to improve palatability.
Dosing Regimen
The evidence supports the following specific approach:
- Starting dose: 30 grams daily, divided into 3-4 doses 1, 2
- Alternative regimen: 40 grams every 8 hours (three times daily) has been used successfully in neurosurgical patients 3
- Lower dose option: 15 grams daily may be effective for milder cases 4
- Preparation: Mix each dose in 100-150 mL of normal saline or juice to mask the bitter taste 3
Clinical Context and Timing
Use urea as second-line therapy when fluid restriction (≤1 liter/day) fails or cannot be implemented 1, 5. The neurosurgical guidelines specifically recommend urea for SIADH patients who do not respond to initial fluid restriction 3.
For patients with severe symptoms (seizures, altered mental status) or acute hyponatremia, hypertonic saline remains first-line; urea is reserved for less severe or chronic cases 3.
Expected Response and Monitoring
- Sodium increase: Expect 2-3 mEq/L increase per day 6, 2
- Time to correction: Sodium typically normalizes (≥135 mEq/L) within 3-6 days 4, 5, 2
- Success rate: 60-80% of patients achieve sodium ≥130 mEq/L within 72 hours 1, 7
Monitor serum sodium every 24 hours initially, then adjust frequency based on response. The retrospective neurosurgical study showed all patients achieved sodium >130 mEq/L within 72 hours using the 40g every 8 hours regimen 3.
Safety Profile
Urea demonstrates excellent safety with minimal risk of overcorrection compared to tolvaptan (3.2% vs 10.8% overcorrection rate) 7. No cases of osmotic demyelination syndrome have been reported in the available studies 1, 6, 5, 2.
Common Side Effects and Management
- Distaste/palatability issues: Occurs in 50-54% of patients 6, 5
- Nausea: Rare, typically mild 5
- BUN elevation: Expected pharmacologic effect, not clinically significant 6
Duration of Treatment
Continue urea for 1-2 days after sodium normalizes, then reassess the underlying cause 3. In neurosurgical patients, treatment typically lasts 1-2 days total. For chronic SIADH (e.g., malignancy-related), longer-term use is safe and effective, with some patients treated for months 8.
Comparative Effectiveness
Recent high-quality evidence shows urea achieves similar sodium normalization rates as tolvaptan (79.7% vs 78.0%) but at dramatically lower cost (€12 vs €468) and with fewer overcorrections 7. While tolvaptan corrects sodium slightly faster (2 vs 3 days to target), urea's safety profile and cost-effectiveness make it the preferred option for most hospitalized patients with SIADH 7, 9.
Critical Caveats
- Do NOT use in cerebral salt wasting (CSW): These patients require volume expansion with normal saline, not urea. Fluid restriction in CSW increases cerebral infarction risk 3
- Avoid in severe/symptomatic hyponatremia: Use hypertonic saline first for seizures, coma, or acute symptomatic hyponatremia 3
- Not for subarachnoid hemorrhage with vasospasm risk: These patients need hypertonic saline to maintain higher sodium targets 3